Fennec Pharmaceuticals (FENC) Notes Payables (2010 - 2017)
Fennec Pharmaceuticals (FENC) posted Notes Payables of $167.0 million for Q4 2017, up 44672.12% on a QoQ basis from $373000.0 in Q3 2017, and up 505960.61% year-over-year from N/an in Q4 2016.
Fennec Pharmaceuticals (FENC) Notes Payables (2010 - 2017) Analysis & Trends
Fennec Pharmaceuticals' Notes Payables history runs 8 years deep, the most recent figure standing at $167.0 million for Q4 2017.
- Quarterly Notes Payables rose 505960.61% year-over-year to $167.0 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $167.0 million (up 505960.61% YoY) and the FY2017 annual result came in at $167.0 million, up 505960.61% from the prior year.
- Notes Payables was $167.0 million for Q4 2017 at Fennec Pharmaceuticals, up from $373000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $167.0 million in Q4 2017 and bottomed at $33000.0 in Q4 2016.
- A 5-year average of $10.2 million and a median of $533500.0 in 2015 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2015 — Notes Payables tumbled 97.34% — and 2017, when it soared 505960.61%.
- Fennec Pharmaceuticals' Notes Payables stood at $2.9 million in 2013, then plunged by 53.93% to $1.3 million in 2014, then slumped by 93.78% to $82000.0 in 2015, then plunged by 59.76% to $33000.0 in 2016, then surged by 505960.61% to $167.0 million in 2017.
- Business Quant data shows FENC's Notes Payables at $167.0 million in Q4 2017, $373000.0 in Q3 2017, and $190000.0 in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 167.00 Mn |
| Sep 30, 2017 | 373,000.00 |
| Jun 30, 2017 | 190,000.00 |
| Mar 31, 2017 | 71,000.00 |
| Dec 31, 2016 | 33,000.00 |
| Sep 30, 2016 | 37,000.00 |
| Jun 30, 2016 | 56,000.00 |
| Mar 31, 2016 | 39,000.00 |
| Dec 31, 2015 | 82,000.00 |
| Sep 30, 2015 | 93,000.00 |
| Jun 30, 2015 | 309,000.00 |
| Mar 31, 2015 | 694,000.00 |
| Dec 31, 2014 | 1.32 Mn |
| Sep 30, 2014 | 3.50 Mn |
| Jun 30, 2014 | 5.34 Mn |
| Mar 31, 2014 | 5.52 Mn |
| Dec 31, 2013 | 2.86 Mn |
| Sep 30, 2013 | 4.39 Mn |
| Jun 30, 2013 | 2.68 Mn |
| Mar 31, 2013 | 10.21 Mn |